Kenya-ARV-Guidelines-2022-2 Year 4 Paediatrics Notes

Kenya-ARV-Guidelines-2022-2 Year 4 · Paediatrics Collection: 4TH YEAR ALL NOTES / PAEDS / PAEDRIATICS / AGISA DR -- Kenya HIV Prevention and Treatment Guidelines, 2022\n\n2022 Edition \n\n© National AIDS & STI Control Program 2022\n\nThis guideline document is a publication of the National AIDS & STI Control Program, Ministry of Health Kenya. No part of this publication may be reproduced, distributed, or transmitted in any form or by any means, including photocopying or recording, without the prior written permission of the National AIDS and STI Control Program (NASCOP), Ministry of Health Kenya, except for non-commercial uses permitted by copyright law.\n\nKenya HIV Prevention and Treatment Guidelines, 2022 edition contain relevant information required by healthcare providers in the use of ARVs as of the date of issue. All reasonable precautions have been taken by NASCOP to verify the information contained in this guideline document.\n\nFor clarifications contact National AIDS and STI Control Program (NASCOP) at P. O. Box 19361 - 00202, Nairobi Kenya, Tel: +254 (020) 2630867, Email: info@nascop.or.ke, Website: www.nascop.or.ke The recommended citation for this document is: Ministry of Health, National AIDS & STI Control Program. Kenya HIV Prevention and Treatment Guidelines, 2022 Edition. Nairobi, Kenya: NASCOP, Aug 2022. Print.\n\nDesign and Layout: Collins Etemesi - NASCOP ISBN: 978-9914-743-61-6 \n\nForeword Kenya is committed to achieving the UNAIDS 95–95–95 testing and treatment targets among people living with HIV within all sub-populations and age groups. The Kenya HIV Prevention and Treatment Guidelines, 2022 is an update of the comprehensive HIV prevention, Care and treatment guidelines released in 2018. These guidelines are aligned with the Ministry of Health’s mission of providing the highest standard of health for all Kenyans and one of the Government of Kenya’s Big Four Agenda on Universal Health Coverage. The theme of the 2022 guidelines is refocusing efforts in the management of Advanced HIV Disease to reduce HIV/AIDS related morbidity and mortality. While Kenya has made tremendous progress in HIV Prevention, Care and Treatment through introduction of better medicines, diagnostics and patient centered approaches in service delivery, Advanced HIV Disease continues to be a challenge. These guidelines intend to widen access to key diagnostics and medicines to manage the most common causes of illness and death. Further, emphasis on integrated delivery of patient-centered HIV, TB, NCDs, mental health and sexual and reproductive health services has been included. These guidelines provide key recommendations on HIV testing services and linkage to prevention and treatment; initial evaluation and follow up of PLHIV; standard package of care for PLHIV; adherence preparation monitoring and support; antiretroviral therapy in infants, children, adolescents and adults; prevention of mother to child transmission of HIV, Syphilis and Viral Hepatitis; TB/HIV coinfection; Hepatitis B & C/HIV co-infection; use of ARVs for post and preexposure prophylaxis for HIV uninfected populations; and HIV services for people who inject drugs. The guidelines are an important tool meant to be used by service providers at all levels of the health sector in Kenya. They are presented in a simplified manner using a public health approach to HIV prevention and treatment. It is my hope that this guidance document provides the much-needed framework and impetus to move towards universal access for HIV services and the agenda of ending AIDS by 2030 as a key national health strategic objective.\n\nDr. Patrick Amoth, EBS Ag. Director General for Health, Ministry of Health.\n\n i \n\nAcknowledgements\n\nThe Kenya HIV Prevention and Treatment Guidelines, 2022 (previously 2018 Guidelines on Use of Antiretroviral Drugs for Treating and Preventing HIV Infection) has been a long-awaited document as the revision was greatly affected by the COVID-19 pandemic. The document has been updated through the collaborative effort of multiple stakeholders, both individuals and institutions, that contributed to the extensive consultations led by NASCOP HIV Care and Treatment Program.\n\nWith much appreciation, I acknowledge all the institutions, both local and international, government ministries and departments whose staff spent long hours, both virtually and in person, in the review, writing and finalization of this document.\n\nI take this opportunity to appreciate the efforts of the Ministry of Health officers at NASCOP and other institutions who coordinated and provided leadership during the review process. Compliments to the guidelines review secretariat and the special task force who worked tirelessly to ensure that the team produced a great quality document. Particular appreciation to the NASCOP team and numerous TA’s who were instrumental in compiling the evidence review and developing the guidelines. Special thanks to the consultants; Jeremy P